| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 传染病检测(元) | 613,856,334.19 | 379,346,463.02 | 1,042,046,491.96 | 481,064,872.57 |
| 慢性疾病检测(元) | 864,609,980.11 | 563,337,286.94 | 1,368,813,985.77 | 761,928,173.27 |
| 毒品(滥用药物)检测(元) | 295,063,172.50 | 144,936,256.55 | 286,462,028.18 | - |
| 妊娠及优生优育检测(元) | 249,223,116.10 | 138,221,708.37 | 293,529,006.27 | - |
| 其他类(元) | 64,077,469.75 | - | 73,957,884.48 | - |
| 营业成本(元) | ||||
| 传染病检测(元) | 277,580,952.11 | 152,755,061.98 | 436,641,925.49 | 193,633,396.15 |
| 慢性疾病检测(元) | 301,905,829.86 | 152,868,264.22 | 330,183,243.64 | 191,515,944.48 |
| 毒品(滥用药物)检测(元) | 132,572,470.22 | 64,124,690.86 | - | - |
| 妊娠及优生优育检测(元) | 141,306,662.30 | 77,477,072.88 | - | - |
| 其他类(元) | 44,487,206.31 | - | - | - |
| 毛利(元) | ||||
| 传染病检测(元) | 336,275,382.08 | 226,591,401.04 | 605,404,566.47 | 287,431,476.42 |
| 慢性疾病检测(元) | 562,704,150.25 | 410,469,022.72 | 1,038,630,742.13 | 570,412,228.79 |
| 毒品(滥用药物)检测(元) | 162,490,702.28 | 80,811,565.69 | - | - |
| 妊娠及优生优育检测(元) | 107,916,453.80 | 60,744,635.49 | - | - |
| 其他类(元) | 19,590,263.44 | - | - | - |
| 毛利率(%) | ||||
| 传染病检测(%) | 54.78 | 59.73 | 58.10 | 59.75 |
| 慢性疾病检测(%) | 65.08 | 72.86 | 75.88 | 74.86 |
| 毒品(滥用药物)检测(%) | 55.07 | 55.76 | - | - |
| 妊娠及优生优育检测(%) | 43.30 | 43.95 | - | - |
| 其他类(%) | 30.57 | - | - | - |
| 收入构成(%) | ||||
| 传染病检测(%) | 29.42 | 30.95 | 34.00 | 38.70 |
| 慢性疾病检测(%) | 41.43 | 45.96 | 44.66 | 61.30 |
| 毒品(滥用药物)检测(%) | 14.14 | 11.82 | 9.35 | - |
| 妊娠及优生优育检测(%) | 11.94 | 11.28 | 9.58 | - |
| 其他类(%) | 3.07 | - | 2.41 | - |
| 毛利构成(%) | ||||
| 传染病检测(%) | 28.28 | 29.10 | 36.82 | 33.51 |
| 慢性疾病检测(%) | 47.33 | 52.72 | 63.18 | 66.49 |
| 毒品(滥用药物)检测(%) | 13.67 | 10.38 | 0.00 | - |
| 妊娠及优生优育检测(%) | 9.08 | 7.80 | 0.00 | - |
| 其他类(%) | 1.65 | - | 0.00 | - |